Biozol GmbH reposted this
Incidence of Mpox has increased with a recent global outbreak that began in May, 2022. Though a vaccine is available, more research focusing on MPXV biology and antiviral drug development is essential. GeneTex is mobilizing its recombinant antibody production platform to establish a catalog of unique monoclonal antibody reagents to facilitate Mpox research. Explore our antibodies for your Mpox research below! https://lnkd.in/gzSBn3f9
